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volume depletion. The mean weight loss in the NT was 1.22 kg,
and in the HPT was 1.36 kg. None of the patients had orthostatic
hypotension, and their response to isometric exercise was normal.
The NT had a normal response to the Valsalva maneuver (mean
VR, 1.57; controls VR, 1.81) and a normal BBV (BBV, 160 msec;
control BBV, 245 msec). In the HPT, the response to the Valsalva
was significantly impaired (VR, 1.18; P <0.005), and there was an
equally marked reduction in the BBV (BBV, 56.6 msec; P <
0.005). There was ECG evidence of ischemic heart disease in one
and left ventricular hypertrophy in two of the HPT. The YR
showed a negative correlation with increasing MAP (r
—0.57).
Acute volume depletion made no difference to the performance of
either group, although three of the HPT were clinically volume-
overloaded before dialysis. Thus, we conclude that the absence of
orthostatic hypotension and the normal response to isometric
execise imply a largely intact autonomic nervous system. In spite
of this, the VR and BBV were abnormal in the HPT, and it is
assumed that unless there is a parasympathetic defect, other fac-
tors, possibly of cardiac origin, must be responsible. Both the
Valsalva maneuver and BBV alone are inadequate tests of auto-
nomic function.
A study in patients with recurrent renal stones associated with
hypercalciuria and assessment of the response to treatment with
sodium cellulose phosphate. M. L. Zaltsman, A. M. Meyers, L.
Laidley, J. Pettfor, and F. J. Mime. Renal Unit, Department of
Medicine, University of the Witwatersrand and Johannesburg
General Hospital and Metabolic Research Unit, Department of
Paediatrics, Baragwanath Hospital, South Africa. Twenty-one
percent of admissions to the urological service at the Johannesburg
General are for the treatment of primary calcium calculi. Pak et al
categorized recurrent renal stone-formers into absorptive, resorp-
tive, and renal hypercalciurias. Other workers have not found a
high incidence of hypercalciuria in these patients. Therefore, this
study was undertaken to further clarify this point, to categorize
pathogenetic mechanisms, and to accurately gauge the effect of
sodium cellulose phosphate in the treatment of this common prob-
lem. Three groups were investigated: 1) normal controls, 2) idio-
pathic hypercalciurics, 3) patients with either hyperparathyroid-
ism or sarcoidosis. All patients in group 2 had a history of
recurrent urinary calculi, and all patients were randomly referred
and had 24-hr urinary calcium excretions of > 300 mg/24 hr.
Subjects were placed on a diet containing 600 to 800 mg of calcium!
day for the duration of the study. Tests were carried out before and
six weeks after commencement of treatment, and in order to
assess the efficacy of cellulose phosphate, all subjects were fol-
lowed more than one year. The following investigations were
carried Out: 1) calcium 47 absorption, 2) total calcium and phos-
phorus, 3) ionized calcium, 4) 8-hr urine test of Edwards, 5) 6-hr
one-gram calcium load of Pak, 6) serum hydroxycholecalciferol
levels, 7) 24-hr urinary calcium and cAMP levels. The absorption
tests showed clear-cut differences between the groups (viz., group
1, 2.9%; group 2, 3.68%; and group 3, 4.86% of the administered
dose/liter of plasma). Urine isotope levels also were different in the
groups (group 1,0.54%; group 2, 1.09%; group 3, 0.9% of adminis-
tered dose). Mean ionized calciums were: group 1, 2.21 0.11;
group 2, 2.13 0.14 (P < 0.05), and group 3, 2.91 (P < 0.001).
Serum proteins were comparable in all groups. Serum hydroxy-
cholecalciferol levels were normal in all groups. A clear-cut differ-
ence between the three groups was also seen in the urine calcium:
creatinine ratios, returning towards normal after treatment in
group 2. These, plus cyclic AMP results and the 8-hr urine test
results will be presented and discussed. We conclude that these
tests indicate various pathogenetic mechanisms and allow clinical
categorization of patients with hypercalciuria. No cases of normo-
calciuric or renal hypercalciuric stone-formers were found. Two
patients with 'normocalcaemic" hyperparathyroidism were
unearthed and successfully treated. Treatment with sodium cellu-
lose phosphate improved biochemical abnormalities, and the rate
of new stone formation was decreased markedly in all but one
patient.
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Mild glomerulitis with pneumopathy and Pneumococcus bacter-
iemia. H. Beaufils, P. Solal-Celigny, D. Uzzan, M. Lucsko, J.
Guédon. Service de Néphrologie, Service de Pneumologie, Sn-
resnes, France. A 50-yr-old man with Pneumococcus bacteriemia
was admitted to the hospital for a pneumopathy. During the course
of the disease a macroscopic hematuria developed lasting three
days, and persisted microscopically during three weeks. Urina-
lysis revealed a proteinuria (1 g/24 hr) for five days, without
hypertension or renal failure. A renal biopsy, performed 22 days
after the first renal symptom, showed a moderate mesangial hyper-
trophy without hypercellularity and extramembranous deposits
("humps") with deposition of C3. Serum C3, C4, and C3PA were
normal on two occasions, and cryoprecipitate was not detected.
The titer of antistreptolysin 0 was unexpectedly high, 1,200 U to
800 U. The presence of circulating immune complexes was sug-
gested by the inhibition of complement-dependent lymphocyte
rosette formation by the serum of the patient. This observation is
an example of a glomerular disease occuring during the course of a
visceral infection with bacteriemia.
Progressive dialysis myoclonic encephalopathy: Responsibility of
tap water. F. Cartier, P. Al/am, D. Chevet, M. Garré, J. P. Hervé,
and S. Pecker. Clinique des Maladies Infectieuses. Unite de Ne-
phrologie. Hôpital Pontchaillou, Rennes, France. A progressive
encephalopathy, mainly characterized by myoclonus speech disor-
ders and occasionally seizures, occurred in 14 chronic hemodialy-
sis patients, 12 of them dialyzed in the same dialysis center. With
the aim of determining the cause of this syndrome, a comparative
study was made between patients with encephalopathy, patients
without encephalopathy who were dialyzed in the same center or
at home, and some control cases without chronic nephropathy.
Brain grey matter aluminium values in patients with encephalop-
athy were 5.5 sg/g of wet tissue, as compared with 1.5 ng/g in
controls (P < 0.001). White matter manganese values were also
increased : 0.66 ng/g as compared with 0.41 in controls (P <0.01).
Copper, zinc, and iron contents were not different. Blood dialy-
sate, and tap water aluminium levels were significantly higher in
this center than those of home dialysis patients. Dialysate and end
dialysis blood aluminium levels were linearly correlated (P <
Abstracts 435
0.00 1), but cumulative intake of aluminium containing salts was
not higher in patients with encephalopathy than in other dialyzed
patients, and it was not correlated with blood aluminium levels.
These data suggest that this syndrome may be due to metals,
particularly aluminium, contained in tap water used for dialysate
preparation. Aluminium and manganese should be measured in tap
water repeatedly, so that the water can be adequately treated if
necessary.
Hereditary C2 deficiency in patient with lupus erythematosus.
M. Dantant, M. Godin, C. Rivat, D. Gilbert, M. Fontaine, D.
Dubois, B. Cave/icr and J. P. Fi/lastre. Unite I.N.S.E.R.M. U78
and Service de Néphro/ogie, Bois Guillaume, France. A new case
of C2 deficiency in a French family is reported. HLA typing,
polymorphism of properdine factor B (B!), and study of total
complement and fractions showed that gene C2d for C2 deficiency
segregates both with the HLA-A10=B27/Bf2 haplotype and with
the HLA-A9=B7/Bf2 haplotype. C2 deficiency was associated
with an SLE syndrome in a girl; her brother, with the same C2
deficiency, was an apparently healthy boy. Gene C2d was known
to be associated with haplotypes HLA-A10-B18, -A9-B18, All-
B18, and Al0-Bw40. All these haplotypes contained either the B18
or the AlO allele. However, association between C2d gene and
other haplotypes which did not contain the AlO or the B18 alleles
were also found: -A2-B12, -A3-B5, A9-B5, -Aw30-Bl3, -Al-B8,
-A2-B5. In this case, two additional haplotypes inherited together
with the C2d gene were reported. Bf and C2d are found very close
to each other; C2 deficiency was thus always found associated with
the Bf2 allotype.
Hypoglycemic activity of the main metabolite of glibenclamide:
Influence of renal insufficiency. J. Fabre, L. Ba/ant, L. Loutan,
and H. Samimi, Po/iclinique liniversitaire de médecine, Genève,
Switzerland. The administration of 5 mg of '4C-glibenclamide
(GLI) in seven subjects with renal insufficiency showed that a
complete hepatic transformation of GLI into its metabolites lim-
ited the accumulation of the original molecule. On the contrary,
the urinary excretion of the metabolites was reduced (normal, 28%
of the dose in 24 hr; GFR of 32 mi/mm, 18%; GFR of 7 mI/mm,
2.3%). Therefore, it was important to know if the metabolites have
a hypoglycemic activity. Groups of six rats with ligatured ureters
received i.p. 1 mg/kg of GLI, or of its main metabolite, 4-trans-
hydroxyglibenclamide (OH-GLI), or saline. Each rat was paired
with a control animal that had a sham operation. The serum
glucose was measured during 4 hr after injection (glucose oxydase
micromethod). In the controls, GLI caused a significant decline of
the glycemia (P < 0.05), but less marked that with OH-GLI (P <
0.001). Dose-effect curves showed that the relation of the ED30
(dose necessary to reduce the glycemia by 30%) for GLI and OH-
GLI is 6.5. Therefore, the metabolite has a strong activity, not
demonstrated until now, 50 to 100 times greater than tolbutamide
under the conditions of this experiment. In rats with ligatured
ureters, OH-GLI causes a greater hypoglycemic response than in
the controls (P < 0.001). Conclusions. Renal insufficiency, in
man, slowed the excretion of OH-GLI. This metabolite, in the rat,
had a marked hypoglycemic activity, which was increased when
urinary excretion was suppressed. These data permit a better
understanding of the pathogenesis of hypoglycemic manifestations
in patients with renal insufficiency treated with glibenclamide.
Effort hemodynamic data in patients on chronic hemodialysis.
J. P. Fend/er, G. Dongradi, J. C. Kahn, P. Rocha, and M. Ben
Fahrat. Département de Néphrologie and Département de Car-
diologie, Centre Hospitalier Intercommunal de Poissy, France. In
sixteen patients on chronic hemodialysis without patent heart
disease or cardiac failure, hemodynamic data were determined at
bed rest, in sitting position, and at the highest level performed on
the ergometer bicycle (60 or 90 watts): mean right atrial pressure
(RAP), mean pulmonary wedge pressure (PWP), a systolic arterial
pressure (SAP), diastolic arterial pressure (DAP), heart rate (HR),
cardiac output (CO), cardiac index (CI), systolic index (SI), and
lactacidemia (LA). These parameters were correlated with SAP,
DAP, hemoglobin (Hb), and arterioveinous fistula output (
OFAV). At the highest effort performed the values were: RAP, 5.6
4.4 mm Hg; PWP, 17.2 7.8 mm Hg; SAP, 208 42 mm Hg;
DAP, 98 24mm Hg; HR, 129 19 beats/mm; CI, 9.3 2.01/mn-
m2; SI, 73 15 mi/rn2; LA, 2.4 1.1 mEq/liter. Maximum
exertional performed CO is normal when compared to sedentary
normals subjects; PWP is increased at bed rest but is no more
increased for a maximum effort. It was not possible to demonstrate
that either SAP, DAP, PWP, z OFAV, Hb, or lactacidernia might
be the factors lirnitating the maximum exertional cardiac output.
Evidence for a cortico-renal substance inhibiting compensatory
hypertrophy of the kidney. Ch. Fontenaille, J. Lucas, F. Buzelin,
and J. Guenel. Laboratoire de Pathologic Médicale et Néphrolo-
gie, U.E.R. de Médecine, Nantes, France. Increasing number of
cells accounts partly for 'compensatory" growth of contralateral
kidney after nephrectomy. We have tried to inhibit this hyperpla-
sia by infusing into rats cytosol prepared from liver, whole kidney,
cortex, or medulla. We have observed, by comparison with con-
trols, a significant decrease of radioactive thymidine uptake by the
left kidney in animals injected with cytosol of whole kidney or
cortex but not in animals given medulla or liver cytosol. This
experiment supports the assumption that compensatory hyperpla-
sia would result from a lack of growth autoregulation normally
mediated by renal cortex.
Effect of ultrafiltration on plasma levels of parathyroid hormone
(PiPTH). J. F. Dc Fremont, A. Fournier, J. Gueris, B. Coevoet,
G. Lambrey, J. Quichaud, A,niens, France. Lack of renal degra-
dation of PTH contributes to the increase of PiPTH in uremic man.
Polyacrylonitnle membrane (PAN) is permeable to PTH. There-
fore PiPTH was measured in two patients (F,G) at monthly inter-
vals by radioimmunoassay (normal range, 4--8 ng/ml) with plasma
levels of calcium (Ca) and phosphate (PPO4), before and after
hemodialysis (HD) and then ultrafiltration (UF) on PAN. No
difference was observed between the significant decrease of
PiPTH during a HD with three liters of ultrafiltrate and a dialysate
Ca of 7 mg/dl (—49%) and those observed during a UF of 18 liters
with reinfusion fluids containing, respectively, 60(55 4%), 70(53
4%), 80 (52 4%), and 90 (52%) mg of Ca. The ratio ultrafil-
trate:plasma of PTH did not change between the beginning and the
end of UF (0.37 0.09 vs. 0.42 0.10). Study of prefiltration
levels showed the critical role of two parameters: the control of
PPO4 by phosphate binders and the Ca balance during a UF
procedure. The plasma phosphate being constant, the negativity of
this latter (—128 mg of Ca per procedure) led in one month to an
increase of PiPT H from 93 to 146 ng/ml in patient F, whereas in
patient G its positivity (+ 115 mg of Ca per procedure) led in one
month to a fall of PiPTH from 140 to 92 ng/ml. It is stressed that Ca
balance depends not only on Ca concentration in the reinfusion
fluid but also on the weight loss, so that with the standard concen-
tration of 7 rng/dl, this balance varies from -—26 to + 114 mg. The
plasma phosphate being constant, PiVFH before UF was in the
same range as before HD with PAN, when the mean Ca balance of
the previous UP was 60 5 mg. It is concluded that Ca balance
during a UF procedure does not influence PiPTH after UP, a
mirror of its clearance, but has a critical role on PiPTH before UF,
which appears therefore as being mainly the mirror of PTH secre-
tion rate. UF does not appear more effective than HD with PAN in
clearing PT H or in controlling PTH hypersecretion in uremic
patients.
Corticodependent hypercalcemia (HCa) in patients under regu-
lar dialysis treatment (RDT). M. Fuss, J. L. Vanherweghem, P.
Bergman, D. Verbeelen. Department de Nephrologie, Hópital
Universitaire Brugmann, Brussels, Belgium. Among 330 patients
admitted to RDT, three developed persistent HCa (> 2 mg/dl) after
one to six months of RDT. Original kidney diseases were glomeru-
lonephritis, cortical necrosis, and lupus nephritis. All three pa-
tients were dialyzed with 7.5 rng calcium/dI dialysate and treated
436 Abstracts
with Al(OH)3, but no vitamin D (VD) and no calcium supplements
were given. Subtotal parathyroidectomy (PTX) was performed in
two cases for vomiting and painful periarticular calcinosis, but
PTX did not correct HCa. Parathyroid hormone plasma levels
were normal in all three patients, even preoperatively in the two
patients who underwent PTX. In one FIX patient, hypocalcemic
tetany followed immediately prednisone (PDS) administration ne-
cessitated by renal transplantation. In the two other cases, HCa
was corrected after a few days of moderate corticotherapy. Plasma
25(OH)VD was normal in both patients prior to PDS administra-
tion, but whole body retention of 47Ca indicated high normal
values for intestinal calcium absorption. Hyperparathyroidism and
VD intoxication were thus excluded. High-calcium dialysate in
HD patients with high normal calcium absorption could lead to
HCa. Whether PDS acts by decreasing calcium absorption, or by
reducing osteolysis, or by both mechanisms, is still unsolved.
Evidence of a hypovitaminosis PP in the source of chronic renal
insufficiency treated by repeated hemodialysis. A. Gross, D. Pon-
sin, B. Labidi, E. Prenat, J. P. Rivory, andJ. P. Nicolas. Clinical
and Experimental Nephrology, Faculté B de Médecine, Nancy,
France. Vitamin PP was measured systematically in the blood of
54 patients with chronic renal insufficiency treated by repeated
hemodialysis. In all subjects, the concentration of nicotinic acid in
the blood was very low compared to normal subjects, and this
lowering was generally more marked after rather than before
dialysis. The question arises whether this hypovitaminemia plays a
part in the pathogenesis of some of the cutaneous, digestive, and
nervous disturbances observed in these patients. A vitamin re-
placement therapy was instituted, the results of which are difficult
to interpret and give rise to considerable discussion.
Clinical results obtained with a twice-weekly short duration
dialysis strategy. C. Jacobs, I. Reach, J. Rottembourg, and P.
Degoulet. Service de Néphrologie, Groupe Hospitalier Pitié-Sal-
pétrihre, Paris, France. An ultra short dialysis (USD) strategy, 2 x
5 hr per week, was used in 27 patients during a cumulative period
of treatment of 333.5 months. 16 patients were treated with 1 m2
surface area dialyzers with cuprophane membranes, 11 with dialy-
zers of> 1.40 m2 surface area. The selection of patients and the
choice of dialyzers were based on body weight, maximum daily
urinary output, and creatinine clearance. In 12 patients, the results
obtained by USD were compared with those recorded during a
control period of six months' duration during which the patients
were treated according to standard dialysis schedules. In six pa-
tients on USD with 1 m2 dialyzers, the only significant modifica-
tions compared to the control period were a rise of predialysis
plasma level of BUN and of postdialysis plasma levels of BUN and
phosphorus. A decrease in motor nerve conduction velocity
(MNCV) without clinical symptoms was noticed in one patient. In
six patients treated on larger surface area dialyzers, only pre- and
postdialysis values of BUN and creatinine were found to be higher
than during the control period. Out of the group of 27 patients, nine
(33.3%) had to be withdrawn from (JSD: two because of persistent
hyperkalemia and/or hyperphosphatemia (associated with de-
crease of MNCV in one case), two because of pericarditis, one
because of decrease in MNCV, one deliberately when affected by
hepatitis. Elective indications for USD are hospital dialysis pa-
tients weighing 60kg 10, with a daily urinary output of 800 ml,
a residual creatinine clearance of a' 2 mI/mn. Close medical super-
vision is mandatory. USD allows a better rehabilitation of hospital
dialysis patients, and an optimization of dialysis facilities.
Diagnosis of hemolysis and uremia in late pregnancy and puer-
perium: Acute tubular nephritis or thrombotic microangiopathy.
A. Kanjer, L. Morel-Maroger, A. Vandewalle, M. Godin, J.D.
Sraer, 0. Kourilsky, and G. Richer. Service de Néphrologie et
Unite de I'JNSERM, Hopital Tenon, Paris, France. Acute hemol-
ysis and thrombocytopenia occurred in eight of 24 patients admit-
ted over a period of six years for acute renal failure (ARE) during
late pregnancy or puerperium. Six patients had renal biopsy,
showing in three of them acute tubular nephritis (ATN) and throm-
botic microangiopathy (TMA) in the other three. In the three
patients with ATN, pregnancy was complicated by preeclamptic
toxemia or abruptio placentae, and ARF immediately preceded or
followed delivery; two of the three patients had schistocytosis; the
three patients made a complete recovery. In one of the three
patients with TMA, ARF developed at the 22nd week of preg-
nancy complicated by toxemia; in the other two, pregnancy had
been normal and the onset of ARF was delayed up to 2 and 12
weeks after delivery, respectively; two of the three patients had
schistocytosis. The three patients received heparin therapy. Ulti-
mately anuria was persistent in the two patients with TMS who
had arterial-arteriolar lesions; a rapid and complete recovery oc-
curred in the woman who had TMA limited to the glomerular tuft.
This report indicates that the hemolytic-uremic syndrome of late
pregnancy or puerperium may be related to ATN as well as to
TMA. The clinical and hematological features of these two condi-
tions may be indistinguishable. Renal biopsy may allow diagnosis
and therefore prediction of outcome. Also it gives a basis for
heparin therapy in TMA, which seems better indicated when
arteries and arterioles are preserved.
Cancer and transplantation: An additional case report. G. Le-
lievre, M. Ribet, B. Gosselin, Ph. Dequiedt, E. Lepoutre, A.
Tacquet. Service de Médecine Générale et Nephrologie A, Hôpi-
tal Calmette, and Service de Chirurgie, Hôpital Calmerte, and
Laboratoire d'Anaromo-Pathologie, Hôpital Calmette, Lille,
France. We report the case of a 24-yr-old woman, who, because of
a familial nephropathy, received a cadaver kidney transplant. Two
months later she developed nodular lesions in the lungs. A surgical
biopsy showed the metastatic nature of these lesions. In spite of
interrupting immunosuppressive treatment, the patient died six
weeks later. Autopsy study found a renal carcinoma in the trans-
planted kidney. The authors review the literature and discuss the
pathophysiological consequences of this association between car-
cinoma and immunosuppression for transplantation.
Basophil sensitization in shunt nephritis. A. Martini, M. Levy,
M. Broyer, J.F. Hirsch, J. Benveniste. I.N.S.E.R.M. U.30 et 25,
Service de Neurochirurgie, Hopital Necker Enfants-Malades,
Paris, France. In rabbit acute serum sickness, the IgE-basophil
system plays an important role in the deposition of immune com-
plexes (IC) through the release of vasoactive amines from platelets
and the consequent increase in vascular permeability. By contrast,
little is known about the role of basophils in human glomerulo-
nephritis. We have investigated the possibility of the sensitization
of basophils in a case of glomerulonephritis secondary to an
infected ventriculo-atrial shunt. The responsible antigen, i.e., coa-
gulase-negative staphylococcus, has been clearly identified in this
type of immune complex nephritis. The diagnosis of shunt nephri-
tis was made on clinical, biological, and histological data in a 16-yr-
old male. Coagulase-negative staphylococcus was cultured from
blood and ventriculoatrial shunt. Twenty-five days after removal
of the catheter, when blood cultures were sterile, we performed an
in vitro degranulation test in the presence of either the bacteria
cultured from patient's blood or a pooi of coagulase-negative
staphylococcus. A marked degranulation was observed in both
tests. We have therefore demonstrated the presence of a basophil-
dependent hypersensitivity towards an antigen previously present
in the blood and, in all probability, implicated in the pathogenesis
of glomerular damage. This finding substantiates the hypothesis
that IgE-basophil-platelet system might in man contribute to IC
deposition within the glomerular capillary walls.
Acute leukemia complicating renal transplantation. C. Mendes
da Costa-Richard, G. Dc Roy, Y. Thoua, E. Dupont, and J.P.
Naets. Services de Médecine et d'Anatomie Pathologique, Hôpi-
tal Universitaire Brugmann, Brussels, Belgium. A 39-yr-old male,
with chronic interstitial nephritis, treated by kidney transplanta-
tion and immunosuppression (azathioprine and prednisolone) for
11 years, developed acute leukemia. After two months of dialysis,
he received a first cadaver transplant in 1966. In 1969, after
rejection of this graft and a short period of dialysis, he received a
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second cadaver transplant. In 1973, chronic cytomegalovirus hep-
atitis supervened, but liver disease was well-tolerated and graft
function was good, although with moderate leukopenia and throm-
bocytopenia. In March 1977, rupture of oesophagal varices, asso-
ciated with major pancytopenia supervened, and azathioprine was
discontinued. Blood and marrow smears showed numerous blasts,
and the patient died with high fever and diffuse hemorrhages three
months later. Several cases of leukemia have been described after
renal transplantation and alter immunosuppressive therapy alone.
This unusual complication of transplantation could be due to
ailogenic stimulation, immunosuppression, or reactivation of on-
cogenic viruses.
Three cases of total parathyroidectomy and autotranspiantation
of parathyroid tissue in the forearm. A. Meyrier, J.P. Jablonski,
and G. Caillens. Service de Néphrologie, Hop/ta! Tenon, and
Service de Chirurgie Infantile, HOpital Trousseau, Paris, France.
In three cases of chronic renal failure the four hyperplastic pam-
thyroid glands were removed, and 20 slivers of parathyroid tissue
were transplanted intramuscularly in the forearm. Another para-
thyroid gland was preserved by deep freezing for a possible second
transplant. Two patients were suffering from chronic renal failure
of long duration. The third had been hemodialyzed for five years.
All three had bone pain and pruritus. Severe osteoclastic resorp-
tion was conspicuous Ofl X-rays and (in two cases) on the bone
biopsy. The operation and the further clinical course were event-
less. The main biological features were as follows:
Case no. 1
Ph.alc. PTH
Ca P (N=< 85) (N=<1.2)
Preop. 7.5 5.0 180 11.5
D + 7 4.5 7.5 180 0.75
D+90 7.5 5.0 50 1.2
Case no. 2
Ca P Ph. ale. PTH
10.5
5.5
9.5
5.0
4.5
2.5
850
700
160
13
3
1.75
Case no. 3
The clinical and X-ray abnormalities regressed progressively. The
control of hypocalcemia necessitated high amounts of oral cal-
cium, 25-OH-D3 and DHT. Comparative PTH radioimmunoassay
in the brachial veins showed concentrations 1.5- to 20-fold on the
autotranspianted side as compared with peripheral blood. The
PTH secretion rate was stimulated by hypocalcemia and shut-off
by hypercalcemia. This technique has the following advantages
over 7/8 PTX: 1) easy postoperative course; 2) quantified amount
of parathyroid tissue left in the body; 3) possibility of 2nd opera-
tion under local anesthesia for adding or removing parathyroid
fragments if necessary; 4) PTH assay at its source.
The response of the renal kallikrein-kallidin system to unine-
phrectomy in rats. A. Mimran, G. Baudin, D. Case//as, W.C.
Wahbe. Department of Medicine, Montpellier, France. The re-
sponse of urinary kallikrein (BAEE esterase activity) to unine-
phrectomy and the changes of kallikrein to dietary sodium restric-
tion in 1-week (group I) and 5-week (group II) uninephrectomized
rats were investigated. In group I (N = 6), uninephrectomy was
associated with a 40% decrease in urinary kallikrein excretion (U
Kall) from 9.18 0.2 to 6.38 0.8 IU/24 hr (P < 0.005) seven
days alter nephrectomy. Kidney weight increased from 0.92
0.03 to 1.13 0.02 g (P < 0.001). Sodium restriction induced an
increase in U Kall to 10.4 l.5(P <0.025). In group II(N = 6),
U Kall was 7.64 0.8 (before nephrectomy), 4.93 0.65(1 week),
and 6.7 0.45 (5 weeks after nephrectomy). Kidney weight was
1.38 0.02 g (1.10 0.04 control, P < 0.001). After 7 days of
sodium restriction, U Kall increased to 8.5 0.8 (P < 0.05). In
control normal rats, sodium restriction was associated with an
increase in U Kall from 8.3 1.2 to 15.2 1.6 (P < 0.001).
Uninephrectomy is associated with a progressive adaptation of
urinary kallikrein excretion without any correlation with sodium
regulation since UNa V did not change during the study in group I
and II rats. However, uninephrectomy seems to blunt significantly
(especially 5 weeks after nephrectomy) the response of renal
kallikrein to sodium restriction. The role of a change in the re-
sponse of the renin-angiotensin-aldosterone system to sodium re-
striction needs to be investigated.
Utilization of sodium acetate by patients on maintenance hemo-
dialysis (MHD). R. Ou/ès, B. Branger, M. Che va/let, C. Polito, G.
Desch, B. Descomps, C. Mion. Service de Nephrologie, C.H. U.
NImes et Service de Biochimie A, C.H. U. Montpellier, France. In
order to study the metabolic effects of the acetate (SA) load
induced during hemodialysis (HD), plasma SA determinations
were performed by gas chromatography in 34 uremics on MHD.
Dialysis schedule was five hours, 3 times weekly on a Gambro
Lundia l3.5= 1 m2 dialyzer, with a constant QB at 190—450 ml!
mm, QD 500 mI/mm, and dialysate SA at 38.5 mmoles/liter without
dextrose. Three protocols were followed: 1) Plasma SA was deter-
mined before and at the end of HD in 34 patients (2 or 3 times in 15
cases). 2) Plasma SA kinetics were done during HD (5 cases) and
after HD (3 cases). 3) In 16 cases, plasma beta-OH-butyrate
(BHB), acetoacetate (AA), lactate, and pyruvate were also deter-
mined before and at the end of HD. Results are as follows: 1)
Plasma SA level before HD was 0.6 0.04 mmoles/liter, increas-
ing significantly to 5.6 0.68 (range 1.7 to 19 6 mmoles/liter) at the
end of HD. There was no consistent influence of QB, but marked
variations between dialysis sessions were found in the same pa-
tient. 2) Plasma SA increased in all patients, achieving a steady
state with a "plateau" in 5 cases and increasing continuously up to
the end of HD in 2 cases. After HD was completed, a rapid
decrease of plasma SA was observed with an estimated t'/2 of 11
752 150.9 moles/liter) as well as AA (59 7.6 to 508 90.8
moles/liter). There was no correlation between SA level and
BHB and AA levels or BHB/AA at the end of HD, or i.s BHB, or
AA during HD. However, BHB and AA levels at the end of HD
were correlated to the caloric intake before HD (r = — 0.61 and r
=
— 0.62, respectively). Lactate decreased during HD (1121
103.7 to 796 76.9 ILmoles/liter) but not pyruvate (101 14.7 to
98.9 11.1 zmoles/liter). The results indicate a tendency to SA
"accumulation" in some patients during HD, followed by disap-
pearance from plasma after HD. This observation suggests a
variable SA utilization rate among the group of patients. There is
no apparent relation between the SA load and the increase of
ketone bodies in plasma.
Mechanisms of renal compensatory hypertrophy. F. Stephan,
P. Reville, and F. de Laharpe. Hospices Civils de Strasbourg,
Strasbourg, France. The mechanisms of renal compensatory hy-
pertrophy are still poorly understood. A renotropic substance may
appear in the blood after loss of renal tissue. It is more likely that
the blood level of an inhibiting substance is reduced. So hypertro-
phy and hyperplasia may occur until the amount of this substance
is replenished by the growing tissue. According to this hypothesis,
the kidney controls its own growth. The increased work load,
essentially related to tubular sodium reabsorption, is probably not
responsible for initiating kidney regeneration, but it may control
the degree of renal compensatory growth. It may be modffied by
certain metabolic and hormonal disturbances: in the rat, renal
compensatory hypertrophy is enhanced by administration of
ACTH or by diabetes mellitus; it is reduced—but not abolished—
by hypothyroidism.
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Propranolol and pregnancy: Preliminary results of a prospective
study. Ph. Tcherdakoff C. Kreft, F. Berrard. Hdpital Ambroise
Pare, Bonlogne, France. Theoretically, beta-blockers may prove
harmful during pregnancy: there may be increase of uterine con-
tractions (risk of premature birth), fetal bradycardia, neo-natal
hypoglycemia. A preceding retrospective study seemed to mini-
mize these dangers. A prospective study with precise measure-
ments of uterine contractions, fetal cardiac rhythm, neonatal gly-
cemia, and APGAR index has been started in order to support the
initial data. Preliminary results, obtained from a small number of
patients, apparently show that the harmful effects of beta-blockers
during pregnancy are less important than initially thought.
Repeat biopsies in membranous glomerulonephritis (MGN). M.
Zanetti, L.H. Noel, C. Barbanel and D. Droz. Clinique Néphrolo-
gique et Service de Thérapeotique Néphrologique, Hbpital
Necker, Paris, France. Fourteen patients with MGN had repeat
biopsies. All but two had idiopathic MGN. All biopsies were
studied by light microscopy; 18 were examined by immunofluores-
cent and 13 by electron microscopy or on thin sections. Three
stages of lesions of the glomerular capillary wall were observed:
type I: diffuse presence of subepithelial deposits (SED) without
spikes; type II: presence of SED with diffuse spikes; type III:
complex morphological changes of the capillary wall. On the first
biopsy 7 patients were type I and 7 were type II. None had renal
insufficiency. Evolution: A) Complete pathological recovery
(three cases) was observed in two patients with type I and one with
type II lesions, 1.5, 4, and 5 years, respectively, after the first
biopsy. All patients had nonnal urinalysis and normal renal func-
tion at the time of the second biopsy. B) Three patients with type I
had unchanged lesions 6 months to 2 years after first biopsy.
Isolated proteinuria without renal failure persisted in two patients.
One had clinical remission. C) Change of type (eight cases): One
patient with type II lesions on the first biopsy had type I on a
second biopsy performed 10 years later and subsequently had
clinical remission. Two patients with type I on the first biopsy had
type III when re-biopsied after an interval of 3 and 6 years. One
developed renal insufficiency, the other had clinical remission.
Five patients with type lion the first biopsy showed type III on the
second biopsy. The intervals ranged from 6 months to 4 years after
the first biopsy. One developed end-stage renal failure, three had
clinical remission, and one had persistent nephrotic syndrome. In
conclusion, the change from type I through type III does not
always correspond to a progressive worsening of the clinical status
of the patient. All morphological types may change and lead to
complete pathological recovery.
Histopathological course in 55 cases of pregnancy nephropathy.
P. Zech, S. Colon, N. Blanc, M. Labeeuw, and J.P. Chalmet.
Clinique de Néphrologie et des Maladies Métaboliques, Hópital
Edonard Herr/at, Lyon, France. Fifty-five patients with persistent
abnormalities after pregnancy nephropathy (19 recurrent forms)
were studied by 60 renal biopsies performed from less than 3
months (19 cases) to more than one year (9 cases) after the onset of
the disease. Fifty single biopsies showed moderate glomerular
proliferation or cellular swelling, segmental hyaline sclerosis mi-
crohyalinosis, and frequent mesangial hyperplasia. Subentothelial
deposits, chiefly in the arterioles, appeared or increased with time.
Hyperplasia of the juxtaglomerular apparatus was occasionally
noted. Twenty-one immunofluorescent studies revealed arteriolar
C3 deposits in 40% (before 3 months), 58% (between 3 and 6
months), and 56% (after 6 months) of the cases. Except in early
biopsies, there was no glomemlar immune deposition. Fibrin de-
posits decreased with time. Serial biopsies (5 cases) showed a
decrease in the glomerular proliferation; mesangial hyperplasia
and segmental hyaline sclerosis remalned stable. Subendothellal
deposits were frequently seen, malnly on the arterioles, and hyper-
plasia of the juxtaglomerular apparatus occurred in one case. Five
early biopsies revealed vascular C3 deposits (2 cases) and glomer-
ular fibrin deposits (4 cases). C3 deposits were found on all late
biopsies. In conclusion, arteriolar lesions with C3 deposits were
the main findings of prognostic value. They might be correlated
with the subsequent rise of blood pressure, even without
proteinuria.
Transient hypercalcemia associated with Reiter's syndrome in
chronic dialysis patients. J. Zingraff, B. Amor, T. Dr//eke, N.K.
Man, P. Jangers, and J. Crosnier. Clinique Néphrologique, Hdpi-
tal Necker, and I.N.S.E.R.M. U.25, Paris, France. Reiter's syn-
drome, frequently associated with the presence of the intracellular
parasite, Chlamydia trachomatis A in urethral specimens, has
never been reported in dialysis patients. Four (about 10%) of our
hemodialysis patients experienced unexplainable episodes of fever
and acute arthralgias. Their association with conjunctivitis in all
and with urethritis in three orientated us to the diagnosis of
Reiter's syndrome. In all patients, intracellular inclusions highly
suggestive of Chlamydia were demonstrated (in urethral speci-
mens in three patients, in the conjunctiva in one). However, these
inclusions were not cultured. Lymphoblastic transformation in the
presence of a Chlamydia (ornithose-psittacose) antigen was nega-
tive in all, but the test was performed more than one year after the
onset of symptoms. Screening for specific serum antibodies is in
progress. Only one of the patients possessed HLA B27 phenotype.
Three of these four patients had transient elevation of plasma
calcium concentration during the acute phase of the syndrome
(predialysis plasma calcium > 11.5 mg/ 100 ml). This elevation
lasted for three to four weeks. The hypercalcemia might be related
to increased bone resorption due to inflammatory periostitis. A
comparable bone resorbing activity has recently been reported in
hypercalcemic patients with rheumatoid arthritis. To conclude,
the frequency of Reiter's syndrome may be underestimated in
hemodialysis patients. One should evoke this diagnosis when
unexplained fever, arthralgias and/or hypercalcemia complicate
the course of long-term dialysis treatment. Further investigations
on this syndrome should be completed by culture of the intracellu-
lar organism. A study of its epidemiologic distribution in dialysis
patients would be of great interest.
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Syndrome of inappropriate secretion of antidiuretic hormone
(SIADH) and cerebrovascular accidents. V. Beroniade, and A.
Farah. Department of Nephrology, Hotel-Dien de Montréal,
Montreal, Canada. The SIADH is frequently described as a com-
plication of cerebrovascular accidents, but to our knowledge,
there is no published study concerning its incidence and clinical
implications. In a series of 20 patients, we found hyponatremia and
hypoosmolality starting from the first to the fifth day in 15 patients.
The severity of the hyponatremia is not always remarkable; in one
case, however, the sodium plasma level decreased to 105 mEq/liter
